Author Question: After reviewing laboratory results the nurse is concerned that a patient being treated for leukemia ... (Read 49 times)

arivle123 · **on:** Jun 25, 2018

After reviewing laboratory results the nurse is concerned that a patient being treated for leukemia is developing tumor lysis syndrome. What did the nurse assess to make this clinical decision?

Select all that apply.

1. hyperkalemia
2. hyponatremia
3. hypocalcemia
4. hypermagnesemia
5. hyperphosphatemia

Question 2

A patient with acute lymphocytic leukemia will be starting chemotherapy. The nurse should instruct the patient about which medications?

Select all that apply.

1. prednisone
2. cytarabine (Cytoxan)
3. vincristine (Oncovin)
4. asparaginase (Elspar)
5. daunorubicin (Cerubidine)

Tabitha_2016 · **Reply #1 on:** Jun 25, 2018

Answer to Question 1

Correct Answer: 1, 3, 5
Tumor lysis syndrome is a risk in patients with leukemia who are undergoing their initial treatment with chemotherapy. Tumor lysis syndrome develops when a large number of malignant cells are destroyed by treatment with chemotherapy or radiation. The resultant by-products of cell lysis can overwhelm the body's ability to effectively eliminate them, leading to hyperkalemia and hyperphosphatemia with secondary hypocalcemia. Hyponatremia and hypermagnesemia do not occur with tumor lysis syndrome.

Answer to Question 2

Correct Answer: 1, 3, 4, 5
The chemotherapeutic regimen for acute lymphocytic leukemia includes daunorubicin (Cerubidine), an antitumor antibiotic; vincristine (Oncovin), a plant alkaloid; prednisone; and asparaginase (Elspar). Cytarabine (Cytoxan) is used to treat acute myeloid leukemia.